Li-Rung Huang

Title: Li-Rung Huang: Innovator in Vaccination Strategies

Introduction

Li-Rung Huang is a notable inventor based in Bonn, Germany. She has made significant contributions to the field of immunology, particularly in the development of innovative vaccination strategies. Her work focuses on enhancing the effectiveness of vaccines through the use of specific agonists.

Latest Patents

Li-Rung Huang holds a patent for a vaccination strategy that utilizes TLR 9 and TLR 4 agonists. This invention aims to improve the numbers and functionality of CD8 T cells in a prime-jump vaccination strategy. The approach is designed to be particularly effective against both acute and chronic infections caused by intracellular pathogens, as well as for anti-tumor vaccination. Additionally, her patent includes a kit containing a prime agent and a multiplying jump agent to facilitate this vaccination strategy.

Career Highlights

Throughout her career, Li-Rung Huang has worked with prestigious institutions such as Klinikum Rechts der Isar der Technischen Universität München and Technische Universität München. Her experience in these organizations has allowed her to collaborate with leading experts in the field of immunology.

Collaborations

Li-Rung Huang has collaborated with notable colleagues, including Percy Knolle and Mathias Heikenwälder. These partnerships have contributed to her research and the advancement of her innovative vaccination strategies.

Conclusion

Li-Rung Huang's work in developing advanced vaccination strategies showcases her commitment to improving public health through innovative solutions. Her contributions to immunology are significant and continue to influence the field.